nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—retina—acquired immunodeficiency syndrome	0.0152	0.104	CbGeAlD
Dexrazoxane—TOP2B—lymphoid tissue—acquired immunodeficiency syndrome	0.0108	0.074	CbGeAlD
Dexrazoxane—TOP2B—digestive system—acquired immunodeficiency syndrome	0.0107	0.0731	CbGeAlD
Dexrazoxane—TOP2B—blood—acquired immunodeficiency syndrome	0.0102	0.0696	CbGeAlD
Dexrazoxane—TOP2B—bone marrow—acquired immunodeficiency syndrome	0.00983	0.0673	CbGeAlD
Dexrazoxane—TOP2B—spinal cord—acquired immunodeficiency syndrome	0.00979	0.0671	CbGeAlD
Dexrazoxane—TOP2B—vagina—acquired immunodeficiency syndrome	0.00942	0.0645	CbGeAlD
Dexrazoxane—TOP2B—lung—acquired immunodeficiency syndrome	0.00891	0.061	CbGeAlD
Dexrazoxane—TOP2B—nervous system—acquired immunodeficiency syndrome	0.00825	0.0565	CbGeAlD
Dexrazoxane—TOP2B—central nervous system—acquired immunodeficiency syndrome	0.00794	0.0544	CbGeAlD
Dexrazoxane—TOP2A—blood—acquired immunodeficiency syndrome	0.00747	0.0512	CbGeAlD
Dexrazoxane—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.00723	0.0495	CbGeAlD
Dexrazoxane—TOP2A—vagina—acquired immunodeficiency syndrome	0.00692	0.0474	CbGeAlD
Dexrazoxane—TOP2A—lung—acquired immunodeficiency syndrome	0.00655	0.0449	CbGeAlD
Dexrazoxane—TOP2B—brain—acquired immunodeficiency syndrome	0.0063	0.0432	CbGeAlD
Dexrazoxane—TOP2B—lymph node—acquired immunodeficiency syndrome	0.00609	0.0417	CbGeAlD
Dexrazoxane—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.00459	0.271	CbGdCrCtD
Dexrazoxane—TOP2A—lymph node—acquired immunodeficiency syndrome	0.00448	0.0307	CbGeAlD
Dexrazoxane—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.0042	0.248	CbGdCrCtD
Dexrazoxane—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.0042	0.248	CbGdCrCtD
Dexrazoxane—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.122	CbGdCrCtD
Dexrazoxane—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.112	CbGdCrCtD
Dexrazoxane—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00133	CcSEcCtD
Dexrazoxane—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00133	CcSEcCtD
Dexrazoxane—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00133	CcSEcCtD
Dexrazoxane—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00133	CcSEcCtD
Dexrazoxane—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00132	CcSEcCtD
Dexrazoxane—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00132	CcSEcCtD
Dexrazoxane—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00132	CcSEcCtD
Dexrazoxane—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00131	CcSEcCtD
Dexrazoxane—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00131	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00131	CcSEcCtD
Dexrazoxane—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.0013	CcSEcCtD
Dexrazoxane—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.0013	CcSEcCtD
Dexrazoxane—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.0013	CcSEcCtD
Dexrazoxane—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.0013	CcSEcCtD
Dexrazoxane—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00129	CcSEcCtD
Dexrazoxane—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00128	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00127	CcSEcCtD
Dexrazoxane—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00127	CcSEcCtD
Dexrazoxane—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00126	CcSEcCtD
Dexrazoxane—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00126	CcSEcCtD
Dexrazoxane—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00126	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00126	CcSEcCtD
Dexrazoxane—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00125	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00125	CcSEcCtD
Dexrazoxane—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00125	CcSEcCtD
Dexrazoxane—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00104	0.00125	CcSEcCtD
Dexrazoxane—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00125	CcSEcCtD
Dexrazoxane—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00124	CcSEcCtD
Dexrazoxane—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00124	CcSEcCtD
Dexrazoxane—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00124	CcSEcCtD
Dexrazoxane—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00123	CcSEcCtD
Dexrazoxane—Headache—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00123	CcSEcCtD
Dexrazoxane—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00123	CcSEcCtD
Dexrazoxane—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00103	0.00123	CcSEcCtD
Dexrazoxane—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00122	CcSEcCtD
Dexrazoxane—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00122	CcSEcCtD
Dexrazoxane—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00121	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00101	0.00121	CcSEcCtD
Dexrazoxane—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00121	CcSEcCtD
Dexrazoxane—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00121	CcSEcCtD
Dexrazoxane—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00101	0.00121	CcSEcCtD
Dexrazoxane—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00121	CcSEcCtD
Dexrazoxane—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00101	0.0012	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0012	CcSEcCtD
Dexrazoxane—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.0012	CcSEcCtD
Dexrazoxane—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.001	0.0012	CcSEcCtD
Dexrazoxane—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.001	0.0012	CcSEcCtD
Dexrazoxane—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000999	0.00119	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000998	0.00119	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000995	0.00119	CcSEcCtD
Dexrazoxane—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000994	0.00119	CcSEcCtD
Dexrazoxane—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000994	0.00119	CcSEcCtD
Dexrazoxane—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000993	0.00119	CcSEcCtD
Dexrazoxane—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000993	0.00119	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000992	0.00119	CcSEcCtD
Dexrazoxane—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000992	0.00118	CcSEcCtD
Dexrazoxane—Pain—Indinavir—acquired immunodeficiency syndrome	0.000986	0.00118	CcSEcCtD
Dexrazoxane—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000986	0.00118	CcSEcCtD
Dexrazoxane—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000985	0.00118	CcSEcCtD
Dexrazoxane—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000985	0.00118	CcSEcCtD
Dexrazoxane—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000983	0.00117	CcSEcCtD
Dexrazoxane—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00098	0.00117	CcSEcCtD
Dexrazoxane—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00098	0.00117	CcSEcCtD
Dexrazoxane—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000979	0.00117	CcSEcCtD
Dexrazoxane—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000978	0.00117	CcSEcCtD
Dexrazoxane—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000976	0.00117	CcSEcCtD
Dexrazoxane—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000976	0.00117	CcSEcCtD
Dexrazoxane—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000972	0.00116	CcSEcCtD
Dexrazoxane—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000971	0.00116	CcSEcCtD
Dexrazoxane—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00097	0.00116	CcSEcCtD
Dexrazoxane—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000968	0.00116	CcSEcCtD
Dexrazoxane—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000967	0.00116	CcSEcCtD
Dexrazoxane—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000961	0.00115	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000961	0.00115	CcSEcCtD
Dexrazoxane—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000956	0.00114	CcSEcCtD
Dexrazoxane—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000953	0.00114	CcSEcCtD
Dexrazoxane—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00095	0.00113	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000949	0.00113	CcSEcCtD
Dexrazoxane—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000948	0.00113	CcSEcCtD
Dexrazoxane—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000947	0.00113	CcSEcCtD
Dexrazoxane—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000946	0.00113	CcSEcCtD
Dexrazoxane—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000946	0.00113	CcSEcCtD
Dexrazoxane—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000946	0.00113	CcSEcCtD
Dexrazoxane—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000945	0.00113	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000943	0.00113	CcSEcCtD
Dexrazoxane—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000943	0.00113	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000943	0.00113	CcSEcCtD
Dexrazoxane—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000942	0.00113	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00094	0.00112	CcSEcCtD
Dexrazoxane—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000939	0.00112	CcSEcCtD
Dexrazoxane—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000939	0.00112	CcSEcCtD
Dexrazoxane—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000936	0.00112	CcSEcCtD
Dexrazoxane—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000931	0.00111	CcSEcCtD
Dexrazoxane—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000931	0.00111	CcSEcCtD
Dexrazoxane—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000929	0.00111	CcSEcCtD
Dexrazoxane—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000929	0.00111	CcSEcCtD
Dexrazoxane—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.00111	CcSEcCtD
Dexrazoxane—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000925	0.00111	CcSEcCtD
Dexrazoxane—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000923	0.0011	CcSEcCtD
Dexrazoxane—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000921	0.0011	CcSEcCtD
Dexrazoxane—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000918	0.0011	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000917	0.00109	CcSEcCtD
Dexrazoxane—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000916	0.00109	CcSEcCtD
Dexrazoxane—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000912	0.00109	CcSEcCtD
Dexrazoxane—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000912	0.00109	CcSEcCtD
Dexrazoxane—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000911	0.00109	CcSEcCtD
Dexrazoxane—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000911	0.00109	CcSEcCtD
Dexrazoxane—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00091	0.00109	CcSEcCtD
Dexrazoxane—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000909	0.00109	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000908	0.00108	CcSEcCtD
Dexrazoxane—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000907	0.00108	CcSEcCtD
Dexrazoxane—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000906	0.00108	CcSEcCtD
Dexrazoxane—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000903	0.00108	CcSEcCtD
Dexrazoxane—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000901	0.00108	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.0009	0.00107	CcSEcCtD
Dexrazoxane—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000898	0.00107	CcSEcCtD
Dexrazoxane—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000897	0.00107	CcSEcCtD
Dexrazoxane—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000896	0.00107	CcSEcCtD
Dexrazoxane—Headache—Stavudine—acquired immunodeficiency syndrome	0.000893	0.00107	CcSEcCtD
Dexrazoxane—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000893	0.00107	CcSEcCtD
Dexrazoxane—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000891	0.00106	CcSEcCtD
Dexrazoxane—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000891	0.00106	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000891	0.00106	CcSEcCtD
Dexrazoxane—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000889	0.00106	CcSEcCtD
Dexrazoxane—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000884	0.00106	CcSEcCtD
Dexrazoxane—Headache—Abacavir—acquired immunodeficiency syndrome	0.00088	0.00105	CcSEcCtD
Dexrazoxane—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000879	0.00105	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000878	0.00105	CcSEcCtD
Dexrazoxane—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000877	0.00105	CcSEcCtD
Dexrazoxane—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000877	0.00105	CcSEcCtD
Dexrazoxane—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000872	0.00104	CcSEcCtD
Dexrazoxane—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00087	0.00104	CcSEcCtD
Dexrazoxane—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000868	0.00104	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000866	0.00103	CcSEcCtD
Dexrazoxane—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000865	0.00103	CcSEcCtD
Dexrazoxane—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000861	0.00103	CcSEcCtD
Dexrazoxane—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000861	0.00103	CcSEcCtD
Dexrazoxane—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000859	0.00103	CcSEcCtD
Dexrazoxane—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000859	0.00103	CcSEcCtD
Dexrazoxane—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000859	0.00103	CcSEcCtD
Dexrazoxane—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000857	0.00102	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000852	0.00102	CcSEcCtD
Dexrazoxane—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00085	0.00101	CcSEcCtD
Dexrazoxane—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000848	0.00101	CcSEcCtD
Dexrazoxane—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000847	0.00101	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000845	0.00101	CcSEcCtD
Dexrazoxane—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000843	0.00101	CcSEcCtD
Dexrazoxane—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000839	0.001	CcSEcCtD
Dexrazoxane—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000838	0.001	CcSEcCtD
Dexrazoxane—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000834	0.000997	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000832	0.000994	CcSEcCtD
Dexrazoxane—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000831	0.000992	CcSEcCtD
Dexrazoxane—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000828	0.000989	CcSEcCtD
Dexrazoxane—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000827	0.000988	CcSEcCtD
Dexrazoxane—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000827	0.000988	CcSEcCtD
Dexrazoxane—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.000985	CcSEcCtD
Dexrazoxane—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000824	0.000984	CcSEcCtD
Dexrazoxane—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000824	0.000984	CcSEcCtD
Dexrazoxane—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000824	0.000984	CcSEcCtD
Dexrazoxane—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000824	0.000984	CcSEcCtD
Dexrazoxane—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00082	0.000979	CcSEcCtD
Dexrazoxane—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000815	0.000974	CcSEcCtD
Dexrazoxane—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000806	0.000963	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.000963	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000801	0.000957	CcSEcCtD
Dexrazoxane—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.0008	0.000956	CcSEcCtD
Dexrazoxane—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.0008	0.000955	CcSEcCtD
Dexrazoxane—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.000949	CcSEcCtD
Dexrazoxane—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000793	0.000947	CcSEcCtD
Dexrazoxane—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000793	0.000947	CcSEcCtD
Dexrazoxane—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000789	0.000942	CcSEcCtD
Dexrazoxane—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000789	0.000942	CcSEcCtD
Dexrazoxane—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000788	0.000941	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000788	0.000941	CcSEcCtD
Dexrazoxane—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000787	0.00094	CcSEcCtD
Dexrazoxane—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000781	0.000933	CcSEcCtD
Dexrazoxane—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000776	0.000928	CcSEcCtD
Dexrazoxane—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00077	0.00092	CcSEcCtD
Dexrazoxane—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000769	0.000919	CcSEcCtD
Dexrazoxane—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000765	0.000914	CcSEcCtD
Dexrazoxane—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000764	0.000913	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000764	0.000912	CcSEcCtD
Dexrazoxane—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000763	0.000911	CcSEcCtD
Dexrazoxane—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000762	0.000911	CcSEcCtD
Dexrazoxane—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000762	0.00091	CcSEcCtD
Dexrazoxane—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000762	0.00091	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000758	0.000906	CcSEcCtD
Dexrazoxane—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000757	0.000904	CcSEcCtD
Dexrazoxane—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000757	0.000904	CcSEcCtD
Dexrazoxane—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000748	0.000893	CcSEcCtD
Dexrazoxane—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000745	0.00089	CcSEcCtD
Dexrazoxane—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000737	0.000881	CcSEcCtD
Dexrazoxane—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000737	0.00088	CcSEcCtD
Dexrazoxane—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000736	0.000879	CcSEcCtD
Dexrazoxane—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000733	0.000876	CcSEcCtD
Dexrazoxane—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000733	0.000876	CcSEcCtD
Dexrazoxane—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000733	0.000875	CcSEcCtD
Dexrazoxane—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000729	0.000871	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000723	0.000864	CcSEcCtD
Dexrazoxane—Headache—Indinavir—acquired immunodeficiency syndrome	0.000722	0.000863	CcSEcCtD
Dexrazoxane—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00072	0.00086	CcSEcCtD
Dexrazoxane—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000713	0.000852	CcSEcCtD
Dexrazoxane—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000703	0.00084	CcSEcCtD
Dexrazoxane—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000699	0.000836	CcSEcCtD
Dexrazoxane—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000699	0.000836	CcSEcCtD
Dexrazoxane—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000692	0.000827	CcSEcCtD
Dexrazoxane—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000691	0.000826	CcSEcCtD
Dexrazoxane—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000689	0.000823	CcSEcCtD
Dexrazoxane—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000685	0.000818	CcSEcCtD
Dexrazoxane—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000682	0.000815	CcSEcCtD
Dexrazoxane—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000682	0.000814	CcSEcCtD
Dexrazoxane—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000665	0.000795	CcSEcCtD
Dexrazoxane—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000663	0.000791	CcSEcCtD
Dexrazoxane—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000659	0.000788	CcSEcCtD
Dexrazoxane—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.000784	CcSEcCtD
Dexrazoxane—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000653	0.00078	CcSEcCtD
Dexrazoxane—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000647	0.000773	CcSEcCtD
Dexrazoxane—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000637	0.000761	CcSEcCtD
Dexrazoxane—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000635	0.000758	CcSEcCtD
Dexrazoxane—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.000758	CcSEcCtD
Dexrazoxane—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.000748	CcSEcCtD
Dexrazoxane—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000619	0.000739	CcSEcCtD
Dexrazoxane—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000613	0.000733	CcSEcCtD
Dexrazoxane—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000613	0.000732	CcSEcCtD
Dexrazoxane—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000605	0.000723	CcSEcCtD
Dexrazoxane—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000604	0.000721	CcSEcCtD
Dexrazoxane—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00059	0.000704	CcSEcCtD
Dexrazoxane—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000585	0.000699	CcSEcCtD
Dexrazoxane—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000581	0.000694	CcSEcCtD
Dexrazoxane—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000572	0.000684	CcSEcCtD
Dexrazoxane—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000563	0.000672	CcSEcCtD
Dexrazoxane—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000554	0.000662	CcSEcCtD
Dexrazoxane—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000551	0.000658	CcSEcCtD
Dexrazoxane—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000526	0.000628	CcSEcCtD
